BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cooles FAH, Isaacs JD. The interferon gene signature as a clinically relevant biomarker in autoimmune rheumatic disease. The Lancet Rheumatology 2022;4:e61-72. [DOI: 10.1016/s2665-9913(21)00254-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Radziszewska A, Moulder Z, Jury EC, Ciurtin C. CD8+ T Cell Phenotype and Function in Childhood and Adult-Onset Connective Tissue Disease. IJMS 2022;23:11431. [DOI: 10.3390/ijms231911431] [Reference Citation Analysis]
2 Plüß M, Piantoni S, Wincup C, Korsten P. Rapid Response of Refractory Systemic Lupus Erythematosus Skin Manifestations to Anifrolumab-A Case-Based Review of Clinical Trial Data Suggesting a Domain-Based Therapeutic Approach. J Clin Med 2022;11:3449. [PMID: 35743519 DOI: 10.3390/jcm11123449] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Cooles FAH, Tarn J, Lendrem DW, Naamane N, Lin CM, Millar B, Maney NJ, Anderson AE, Thalayasingam N, Diboll J, Bondet V, Duffy D, Barnes MR, Smith GR, Ng S, Watson D, Henkin R, Cope AP, Reynard LN, Pratt AG, Isaacs JD; RA-MAP Consortium. Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming. Ann Rheum Dis 2022:annrheumdis-2022-222370. [PMID: 35680389 DOI: 10.1136/annrheumdis-2022-222370] [Reference Citation Analysis]
4 Plüß M, Piantoni S, Tampe B, Kim AHJ, Korsten P. Belimumab for systemic lupus erythematosus - Focus on lupus nephritis. Hum Vaccin Immunother 2022;:2072143. [PMID: 35588699 DOI: 10.1080/21645515.2022.2072143] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]